The National Cancer Data Base report on gastric carcinoma.
about
Neoadjuvant therapy for gastroesophageal adenocarcinomaMagnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removalNeoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series.Current role of surgical therapy in gastric cancerChemotherapy as a component of multimodal therapy for gastric carcinomaSubtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999.Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: setting an evidence-based benchmark for the best-quality cancer careA follow up model for patients with atrophic chronic gastritis and intestinal metaplasiaEvolving role of chemoradiation in the adjuvant treatment of gastric cancer.Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction follFOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancerDistal gastrectomy versus total gastrectomy for distal gastric cancer.Pre-operative chemotherapy for gastric cancer.Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype.A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.Survival Rates for Patients with Resected Gastric Adenocarcinoma Finally have Increased in the United States.The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer.Risk factors for postoperative pneumonia after gastrectomy for gastric cancer.Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?Incidence and mortality from stomach cancer in Japan, Slovenia and the USA.Prognostic Factors of Patients With Transmural Advanced Gastric Carcinoma.Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.Heat shock protein 70 (HSP70) expression is associated with poor prognosis in intestinal type gastric cancer.Prospective phase II study evaluating the efficacy of swallow ability screening tests and pneumonia prevention using a team approach for elderly patients with gastric cancer.Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
P2860
Q26746147-4C428F33-675E-4F9F-AF6F-2167536E6EAEQ26864245-63D7333D-0F34-4BB5-8CA4-DD8F42B4D054Q33650849-3866B1F8-06CD-43BF-8A92-13B7CE9A2591Q33788203-57C0CFCD-186F-45AC-925A-F86F1F48E016Q33867249-65939EB5-CEDF-46DC-9D8E-326C02957336Q34504614-E7B0C177-E474-4679-8768-A9B0E24DBE97Q34638268-521296A4-DEFD-4978-93AB-4AB9866EF42BQ34689694-548CE093-2E97-48E5-A379-056BA43C7051Q35086851-F162239C-A920-4332-BA07-02C4BD12CFD9Q35228253-7E0066C6-277D-4671-81FF-EC5CC19ED1F8Q35344701-9E51B80E-231A-4C1E-A9B5-CF5778D4D128Q35587381-BFC9453D-0743-4184-9A80-6A98CFD1F95CQ35843686-5AB4D63A-1178-4356-8860-AD1DEE3DD023Q36516605-E3CED066-C6FC-4BA8-9344-DD51B79B2DC3Q37434552-9D27811A-C6DA-4497-B6F4-11EEE4BC81D8Q37626654-0B5BC1EF-5BAD-4880-A2BB-AE15BCECC302Q37636574-2FD8A64E-F2CF-42A8-B6D2-F0F63185C41FQ37727194-6642B103-2DD4-40F7-B60B-868F69C288EAQ37780473-08D6C208-A3B5-4342-A567-2614F6F857DAQ40126401-BC02C4AE-5C50-4E7C-A416-5CF394621509Q40531535-0AA9154F-4C5A-492C-B464-0225F42A28E3Q41370888-4F8998AF-09A6-46E1-9902-4EF86D9CF741Q41667505-308ACA4E-7A54-4562-AB5A-794CB88FD959Q43815683-5BF4944F-5E51-4C41-B38D-D62E6C1254B3Q44117163-3875FFDE-5CBC-4DB2-BFC6-2CFF61459D34Q44889528-6CCFC393-1CE6-4186-B5E2-7B2C26EADA0AQ47138878-A6F25F56-DA06-472E-9EBC-6447490C462FQ47267049-AFCAB28B-FE8C-4DA2-945E-EF2D69AFA25AQ47863981-3D3CE874-8C9B-44A2-BAD5-DE27B7F43D3CQ48005966-AE860400-4F3F-4FC9-8C7F-34F4EEAB528EQ50465037-E8153363-79A2-4E42-8508-90FB0DA12E43
P2860
The National Cancer Data Base report on gastric carcinoma.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The National Cancer Data Base report on gastric carcinoma.
@ast
The National Cancer Data Base report on gastric carcinoma.
@en
type
label
The National Cancer Data Base report on gastric carcinoma.
@ast
The National Cancer Data Base report on gastric carcinoma.
@en
prefLabel
The National Cancer Data Base report on gastric carcinoma.
@ast
The National Cancer Data Base report on gastric carcinoma.
@en
P2093
P2860
P1433
P1476
The National Cancer Data Base report on gastric carcinoma.
@en
P2093
Hundahl SA
Mansour EG
Winchester DP
P2860
P304
P356
10.1002/(SICI)1097-0142(19971215)80:12<2333::AID-CNCR15>3.0.CO;2-V
P407
P577
1997-12-01T00:00:00Z